0.51
-0.0823(-13.95%)
Currency In USD
| Previous Close | 0.59 |
| Open | 0.6 |
| Day High | 0.6 |
| Day Low | 0.45 |
| 52-Week High | 7.2 |
| 52-Week Low | 0.45 |
| Volume | 37.07M |
| Average Volume | 1.75M |
| Market Cap | 2.23M |
| PE | -0.05 |
| EPS | -9.28 |
| Moving Average 50 Days | 1.14 |
| Moving Average 200 Days | 1.85 |
| Change | -0.08 |
If you invested $1000 in 60 Degrees Pharmaceuticals, Inc. (SXTP) since IPO date, it would be worth $8.99 as of February 05, 2025 at a share price of $0.505. Whereas If you bought $1000 worth of 60 Degrees Pharmaceuticals, Inc. (SXTP) shares 1 year ago, it would be worth $136.06 as of February 05, 2025 at a share price of $0.505.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
3 hours ago
WASHINGTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced that it has entered into def
60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Jan 30, 2025 7:20 PM GMT
WASHINGTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the closing of its previousl
60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Jan 29, 2025 1:00 PM GMT
WASHINGTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced that it has entered into def